Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Waverley Pharma Inc V.WAVE

Healthcare Biotechnology
Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:WAVE)

Waverley Pharma Acquires US based Pharmacy

Canada NewsWire September 23, 2024

Waverley Pharma Announces Annual and Special Meeting Election Results

Canada NewsWire June 20, 2024

Waverley Pharma Business Update

Canada NewsWire April 30, 2024

Waverley Pharma Announces Changes to Board of Directors

Canada NewsWire November 22, 2023

Waverley Pharma Business Update

Canada NewsWire August 2, 2023

Waverley Pharma Provides Business Update

Canada NewsWire March 20, 2023

Waverley Pharma Provides Update on its PARP-1 Inhibitor Program

Canada NewsWire January 11, 2023

Waverley Pharma Announces $3,000,000 Credit Facility

PR Newswire August 5, 2021

Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS England

Canada NewsWire May 27, 2021
View More News ››

Opinion & Analysis (TSXV:WAVE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:WAVE)

Pemetrexed

Waverley pharma's pemetrexed sold at drugs.com from May 25th Generic Alimta Availability - Drugs.com - https://www.drugs.com...
Johnmeco - July 7, 2022

??

Aurelio ?????
bigstar10 - July 4, 2022

Notice of the meeting and record date

https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00042362 Do you what this notice means? Is the record date where...
Johnmeco - April 12, 2022

Today's Europe market

Not much volume but what happen European market today...
Johnmeco - March 16, 2022

RE:After 6 months

I first bought this one 2 years ago and kept buying almost every month. I lost over 20k so far but I can wait a couple more years and...
Johnmeco - February 15, 2022

After 6 months

European market is just warming up, USA market is totally different. Dr. Friesen said European market is small and very low price but USA...
Johnmeco - February 15, 2022
View more Bullboard ››

Benton Resources Inc.

Benton Resources Inc.

Benton Resources Inc. is a mineral exploration company listed on the TSX Venture Exchange under the symbol BEX. Benton has a ...
View More »